Dr. Michael Tan
Co-Founder, Group Chief Executive Officer, and Executive Director
Dr. Michael Tan is our Co-Founder, Group Chief Executive Officer, and an Executive Director.
He was previously with Parkway Shenton Singapore, where he served as Chief Executive Officer of Parkway East Hospital from 2008 to 2010. He was also Vice President (Business Development) from 2007 to 2008, and Medical Director from 2003 to 2007.
Dr. Michael holds a Master of Business Administration (MBA) from Imperial College of Science, Technology and Medicine. He also holds a Bachelor of Medicine and Bachelor of Surgery (MBBS), Graduate Diploma in Family Practice Dermatology and a Graduate Diploma in Occupational Medicine from the National University of Singapore. Dr. Michael is currently attending the Owner/President Management Programme at Harvard Business School.
Co-Founder, Group President, and Executive Deputy Chairman of the Board
David Sin is our Co-Founder, Group President, and Executive Deputy Chairman of the Board. He was the Executive Chairman of our Company from 2012 to 2016.
David is the Co-Founder and Chairman of Fullerton Health Foundation, and the Founder and Chief Executive Officer of SIN Capital Group. His prior work experience includes investment banking and special situations investing at American International Group (AIG) Investment Corporation in Hong Kong from 2007 to 2008, and Goldman Sachs in London and Hong Kong from 2003 to 2005.
David holds a Master of Business Administration (MBA) from Harvard Business School, and a Bachelor of Arts (Economics) (Honours) in Accounting and Finance from the University of Manchester.
Dr. Daniel Chan
Co-Founder, Group Deputy Chief Executive Officer, President of Fullerton Health China, and Executive Director
Dr. Daniel Chan is our Co-Founder, Group Deputy Chief Executive Officer, President of Fullerton Health China, and an Executive Director. He was also Regional Managing Director, Singapore and Malaysia until February 2018.
He was previously Chief Operating Officer of Parkway East Hospital from 2008 to 2010, and Vice President (Business Development) and Medical Director at Parkway Shenton Singapore from 2004 to 2008.
Dr. Daniel holds a Master of Business Administration (MBA) from the University of Liverpool, Family Physician qualification from the Singapore Medical Council and Advanced Management Programme from Harvard Business School. Dr. Daniel also holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Imperial College of Science, Technology and Medicine and a Graduate Diploma in Occupational Medicine from the National University of Singapore.
Tam Chee Chong
Group Chief Financial Officer, and Senior Managing Director, Office of the Chairman
Tam Chee Chong is our Group Chief Financial Officer, and Senior Managing Director, Office of the Chairman.
He was previously with Deloitte & Touche LLP as Partner of Family Enterprise Consulting, Leader of Southeast Asia (SEA) Private Practice, Deputy Managing Partner of Markets, and Executive Director of Restructuring Services. Prior to these roles, Chee Chong was the Regional Managing Partner, Financial Advisory for Deloitte SEA from 2006 to 2016.
Chee Chong is a Fellow Chartered Accountant of both England & Wales and Singapore.
Ho Kuen Loon
Group Chief Operating Officer, and Regional Managing Director, Australia and Indonesia
Ho Kuen Loon is our Group Chief Operating Officer, and Regional Managing Director, Australia and Indonesia. Prior to his appointment, he was our Group Chief Control, Risk and Corporate Development Officer from 2015 to February 2018, and Group Chief Financial Officer from 2013 to 2015.
His previous positions prior to joining our Company include Group Chief Financial Officer of Keppel Integrated Engineering from 2011 to 2013, Assistant General Manager, Corporate Development of Keppel Offshore & Marine from 2010 to 2011, Partner & Chief Operating Officer of Innosight Asia from 2006 to 2009, and Regional Director, Asia of Innosight LLC from 2004 to 2005.
Kuen Loon holds a Master of Business Administration from Harvard Business School and a Bachelor of Accountancy from Nanyang Technological University. He is a qualified Chartered Financial Analyst and Chartered Accountant of Singapore.
Dr. Ramesh Rajentheran
Group Chief Investment Officer
Dr. Ramesh Rajentheran is our Group Chief Investment Officer.
He was our Group Chief Financial Officer from 2015 to 2018, and was previously in the investment banking sector from 2004 to 2015. His past positions include being a Managing Director at Barclays in Singapore and Hong Kong, Head of Markets & Advisor to Executive Chairman at the Hong Leong Group, an Executive Director at Morgan Stanley in London, and an Associate Director at UBS in London. From 1999 to 2002, Dr. Ramesh was a physician with the National Health Service in the United Kingdom.
He holds a Master of Business Administration with a concentration in finance from London Business School and a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Newcastle.
Dr. Samuel Chong
Group Chief Technology Officer, Fullerton Health
Acting Chief Executive Officer, Fullerton Systems & Services
Dr. Samuel Chong is our Group Chief Technology Officer, Fullerton Health and Acting Chief Executive Officer, Fullerton Systems & Services.
Prior to joining our Company, Dr. Samuel was Head of Global Services & Consulting Global Accounts, of Dell EMC (Asia Pacific & Japan) from 2012 to 2017. He had previously helmed CTO and Regional Director positions from 2008 to 2012 including Hewlett-Packard Company, Cisco Systems and Capgemini UK.
Dr. Samuel holds a Doctor of Philosophy (PhD) in Information Systems, Master of Science (Distinction) in Information System with Semiotics and Bachelor of Science (Honours) degree in Computing Science from Staffordshire University.
Ng Chong Jin
Ng Chong Jin is our General Counsel.
Prior to joining our Company, Chong Jin was Assistant General Counsel at GlaxoSmithKline from 2010 to early 2018. He had formerly held positions as Senior Counsel, Medical Diagnostics and Life Science Division for Asia Pacific at GE Healthcare from 2008 to 2010, and Legal Director (South Asia) for Merck from 2003 to 2007.
Chong Jin holds a Bachelor of Laws Degree from National University of Singapore and is an Advocate & Solicitor of the Supreme Court of Singapore.